Join to View Full Profile
300 Pasteur DrDepartment of RadiologyPalo Alto, CA 94305
Phone+1 913-940-5344
Fax+1 415-883-0877
Dr. Thakur is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Neuroradiology, 2015 - 2017
Stanford Health Care-Sponsored Stanford UniversityResidency, Radiology-Diagnostic, 2012 - 2016
Los Angeles County-Harbor-UCLA Medical CenterInternship, Transitional Year, 2011 - 2012
University of Missouri Kansas City School of MedicineClass of 2011
Certifications & Licensure
CA State Medical License 2012 - 2026
WA State Medical License 2017 - 2020
American Board of Radiology Diagnostic Radiology
American Board of Radiology Neuroradiology
Publications & Presentations
PubMed
- 26 citationsArterial-spin labeling MRI identifies residual cerebral arteriovenous malformation following stereotactic radiosurgery treatmentJeremy J Heit, Neil H. Thakur, Michael, Nancy J. Fischbein, Max Wintermark
Journal of Neuroradiology = Journal De Neuroradiologie. 2020-02-01 - 21 citationsEvaluating Two Measures of Lumbar Spine MRI Overuse: Administrative Data Versus Chart ReviewTigran Avoundjian, Risha Gidwani, Dorcas Yao, Jeanie Lo, Patricia Sinnott
Journal of the American College of Radiology. 2016-09-01 - 5 citationsFindings and patterns on MRI and MR spectroscopy in neonates after therapeutic hypothermia for hypoxic ischemic encephalopathy treatment.Neil H. Thakur, Andrew J. Spencer, Howard W Kilbride, Lisa H. Lowe
Southern Medical Journal. 2013-06-01
Press Mentions
FDA Staff Says Biogen’s ALS Drug May Have a ‘Clinical Benefit’ on a Rare Form of the DiseaseMarch 20th, 2023
FDA Makes Moves to Advance ALS Research Ahead of Upcoming Amylyx AdComAugust 12th, 2022
Amylyx Pharmaceuticals Donates CENTAUR Clinical Trial Data and Participant Samples to Help Advance Science in ALS for Future Treatments and DiscoveriesSeptember 13th, 2021- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:










